ORLOFF JOHN J 4
4 · ALEXION PHARMACEUTICALS, INC. · Filed Mar 3, 2020
Insider Transaction Report
Form 4
ORLOFF JOHN J
EVP, Research & Development
Transactions
- Award
Common Stock, par value $.0001 per share
2020-02-28+10,880→ 48,671 total - Tax Payment
Common Stock, par value $.0001 per share
2020-03-02$90.54/sh−1,396$126,394→ 47,275 total - Award
Common Stock, par value $.0001 per share
2019-12-15$93.86/sh+38$3,567→ 47,313 total
Footnotes (4)
- [F1]Award of Restricted Stock Units under the 2017 Incentive Plan. 25% vests on each anniversary of the grant date.
- [F2]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $90.48 - $92.45. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F4]In accordance with the Alexion ESPP, these shares were purchased (for the ESPP purchase period from June 30, 2019 to December 15, 2019) based on 85% of the closing price of the Issuer's common stock on December 15, 2019.